Nanohale Acquires Scil Technology’s ---

Nanohale Acquires Scil Technology’s Development, Formulation, and Analytics Assets


GEN News Highlights: Jan 9, 2012


"Drug delivery technology firm Nanohale has acquired the entire R&D, contract development, and manufacturing organization of Scil Technology. The combined assets and associated workforce are part of Formycon, previously Scil’s formulation services, drug production, and analytical services company, which is now a fully owned subsidiary of Nanohale.  ------------------


Nanohale specializes in the development and commercialization of nanocarrier-based delivery systems for proteins and peptides, and potentially oligonucleotides such as siRNA and miRNA. The firm maintains that the acquired assets provide strong expertise in protein drug development, formulation, and analytics, as a complement to its existing protein formulation platform. “The completion of this transaction marks a significant broadening of the product and service portfolio of the Nanohale group, and will facilitate the further transition from a pure technology-based company into a globally operating specialty pharma company,” remarks Nicolas Combé, Ph.D., CFO.  --------------- "


http://www.genengnews.com/gen-news-highlights/nanohale-acquires-scil-technology-s-development-formulation-and-analytics-assets/81246175/


http://www.nanohale.com/


tags:
nutrigenomics human nutrition food safety food wars hunger malnutrition poverty genetics nanotechnology robotics kurzweil monsanto dupont pioneer corn genetically modified usda fda eggs beef poultry pork turkey fish shellfish fruits vegetables food borne illness wheat rice oats barley sorghum soybeans alfalfa protein vitamins minerals amino acids fats unidentified growth factors fatty acids genetic engineering climate change food security agribusiness fresh produce desertification  nanoliposomes solid lipid nanoparticles nanoemulsions